TScan Therapeutics, Inc. (TCRX)
Market Open
26 Oct, 07:46 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 19
-0.02
-8.4646%
$
14.67M Market Cap
- P/E Ratio
- Div Yield
766,009 Volume
-1.04 Eps
$ 0.2
Previous Close 
Want to track TCRX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
TScan Therapeutics, Inc. (TCRX) Reports Q2 Loss, Lags Revenue Estimates
TScan Therapeutics, Inc. (TCRX) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus Estimate of a loss of $0.30. This compares to loss of $0.51 per share a year ago.
Zacks | 2 years ago
2026 © Marketlog. All Rights Reserved.
